These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues. Geers C; Colin IM; Gérard AC Thyroid; 2011 Dec; 21(12):1323-30. PubMed ID: 22066479 [TBL] [Abstract][Full Text] [Related]
9. Expression of human pendrin in diseased thyroids. Kondo T; Nakamura N; Suzuki K; Murata S; Muramatsu A; Kawaoi A; Katoh R J Histochem Cytochem; 2003 Feb; 51(2):167-73. PubMed ID: 12533525 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of aquaporins and its diagnostic utility in thyroid cancer. Niu D; Kondo T; Nakazawa T; Kawasaki T; Yamane T; Mochizuki K; Kato Y; Matsuzaki T; Takata K; Katoh R PLoS One; 2012; 7(7):e40770. PubMed ID: 22808259 [TBL] [Abstract][Full Text] [Related]
11. Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Sequeira MJ; Morgan JM; Fuhrer D; Wheeler MH; Jasani B; Ludgate M Thyroid; 2001 Nov; 11(11):995-1001. PubMed ID: 11762722 [TBL] [Abstract][Full Text] [Related]
12. Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues. Hoang-Vu C; Dralle H; Scheumann G; Maenhaut C; Horn R; von zur Mühlen A; Brabant G Exp Clin Endocrinol; 1992; 100(1-2):51-6. PubMed ID: 1281780 [TBL] [Abstract][Full Text] [Related]
13. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790 [TBL] [Abstract][Full Text] [Related]
14. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer. Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023 [TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337 [TBL] [Abstract][Full Text] [Related]
16. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma. Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630 [No Abstract] [Full Text] [Related]
17. Expression of nitric oxide synthase III in human thyroid follicular cells: evidence for increased expression in hyperthyroidism. Colin IM; Kopp P; Zbären J; Häberli A; Grizzle WE; Jameson JL Eur J Endocrinol; 1997 Jun; 136(6):649-55. PubMed ID: 9225730 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidism. Badziong J; Ting S; Synoracki S; Tiedje V; Brix K; Brabant G; Moeller LC; Schmid KW; Fuhrer D; Zwanziger D Eur J Endocrinol; 2017 Sep; 177(3):243-250. PubMed ID: 28576880 [TBL] [Abstract][Full Text] [Related]
19. Intermediate microRNA expression profile in Graves' disease falls between that of normal thyroid tissue and papillary thyroid carcinoma. Pohl M; Grabellus F; Worm K; Arnold G; Walz M; Schmid KW; Sheu-Grabellus SY J Clin Pathol; 2017 Jan; 70(1):33-39. PubMed ID: 27371612 [TBL] [Abstract][Full Text] [Related]
20. Expression pattern of iodotyrosine dehalogenase 1 (DEHAL1) during chick ontogeny. Mathi AA; Gaupale TC; Dupuy C; Subhedar N; Bhargava S Int J Dev Biol; 2010; 54(10):1503-8. PubMed ID: 21302259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]